Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JD Health InternationalJDHIF 91 Graham Number is $4.21 as of Jun. 2026, which is 142% above its 10-year median of 1.74. GuruFocus rates JDHIF with a GF Score™ of 91/100 and a GF Value™ of $7.67. The stock has 1 warning sign investors should review. Among 370 Healthcare Providers & Services companies, JD Health International ranks better than 61.35% on this metric.
Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.
The historical rank and industry rank for JD Health International's Graham Number or its related term are showing as below:
JDHIF'
s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1 Med: 1.74 Max: 9.62
Current: 1.2
During the past 9 years, the highest Price to Graham Number ratio of JD Health International was 9.62. The lowest was 1.00. And the median was 1.74.
JDHIF's Price-to-Graham-Number is ranked better than 61.35% of 370
companies
in the Healthcare Providers & Services industry
Industry Median: 1.655
vs JDHIF: 1.20
Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.
JD Health International (OTCPK:JDHIF) Graham Number Explanation
Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:
Current price should not be more than 15 times average earnings of the past three years.
Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)
Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.
In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.
JD Health International's Price to Graham number Ratio for today is calculated as
Price to Graham number
=
Share Price (Today)
/
Graham number (Q: Jun. 2026 )
=
5.85
/
4.21
=
1.39
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Please keep these in mind:
1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.
JD Health International Graham Number Related Terms
JD Health International Graham Number Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JD Health International Graham Number Competitor Comparison
For the Pharmaceutical Retailers subindustry, JD Health International's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JD Health International Price-to-Graham-Number vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's Price-to-Graham-Number distribution charts can be found below:
* The bar in red indicates where JD Health International's Price-to-Graham-Number falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JD Health International (JDHIF) has a Graham Number of $4.21 as of Jun. 2026. The Graham Number values a company based on its per-share earnings and book value. View historical data on JD Health International and its competitors. This is 142% above median its historical median of 1.74. Over the past decade, JD Health International's Graham Number has ranged from 1.00 to 9.62. According to the industry distribution chart, JD Health International ranks #143 out of 370 companies in the Healthcare Providers & Services industry, placing it in the top 38.6%.
Is JD Health International's Graham Number too high?
JD Health International's current Graham Number of $4.21 is 142% above median its 10-year median of 1.74. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 9.62. The Healthcare Providers & Services industry median Graham Number is 1.66. JD Health International's value of $4.21 is 154.4% above this industry median. Based on the distribution chart, JD Health International ranks #143 out of 370 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, JD Health International has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does JD Health International's Graham Number compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, JD Health International ranks #143 out of 370 companies for Graham Number. This puts JD Health International in the upper half of its industry. The industry median Graham Number is 1.66. JD Health International's value of $4.21 is 154.4% above this benchmark. Historically, JD Health International's own Graham Number has ranged from 1.00 to 9.62 over the past decade. While the company's 10-year median is 1.74 vs. the industry median of 1.66, JD Health International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Graham Number for a Healthcare Providers & Services company?
The median Graham Number among Healthcare Providers & Services companies is 1.66, based on 370 companies in the industry. Companies in the top quartile (top 25%) have a Graham Number significantly above this median, while those in the bottom quartile fall well below. However, Graham Number should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JD Health International's current Graham Number of $4.21 is 154.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Graham Number mean?
A high Graham Number can signal that a stock is expensive relative to its fundamentals. The Graham Number values a company based on its per-share earnings and book value. View historical data on JD Health International and its competitors. For the Healthcare Providers & Services industry, the median Graham Number is 1.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JD Health International's current Graham Number is $4.21, which is 142% above median its own 10-year median of 1.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JD Health International stock overvalued right now?
JD Health International (JDHIF) has a current Graham Number of $4.21. The stock's GF Value™ is $7.67, compared to a current price of $5.85 — trading 23.7% below its estimated fair value. The current Graham Number is $4.21, which is 142% above median its 10-year median of 1.74 and 154.4% above the Healthcare Providers & Services industry median of 1.66. JD Health International's overall GF Score™ is 91/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Graham Number calculated?
Graham Number is calculated from a company's financial statements. For JD Health International (JDHIF), the current Graham Number is $4.21 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JD Health International (JDHIF) Overvalued in 2026?
Based on GuruFocus' analysis, JD Health International stock appears to be undervalued.
The current stock price of $5.85 is trading 23.7% below its estimated GF Value™ of $7.67.
Key valuation signals for JDHIF:
Graham Number: $4.21 (142% above median its 10-year median of 1.74)
GF Value™: $7.67 vs. price of $5.85 (23.7% below fair value)
Industry Position: 154.4% above the Healthcare Providers & Services median (#143 of 370)
No single metric tells the full story. See the JDHIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
91GF Score
Get the complete analysis for JDHIF
Graham Number is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JDHIF has been successfully added to your 
